Scorpius Holdings Reports Definitive Agreement and Equity Sales

Ticker: SCPX · Form: 8-K · Filed: Jul 3, 2025 · CIK: 1476963

Scorpius Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyScorpius Holdings, Inc. (SCPX)
Form Type8-K
Filed DateJul 3, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, financial-obligation, equity-sale

TL;DR

Scorpius Holdings inked a deal, took on debt, and sold stock on June 30th.

AI Summary

On June 30, 2025, Scorpius Holdings, Inc. entered into a material definitive agreement and incurred a direct financial obligation. The company also reported on unregistered sales of equity securities. The filing includes financial statements and exhibits related to these events.

Why It Matters

This filing indicates significant corporate actions, including new financial obligations and equity transactions, which could impact the company's financial structure and shareholder value.

Risk Assessment

Risk Level: medium — The filing details material definitive agreements, financial obligations, and unregistered equity sales, which can introduce financial and operational risks.

Key Players & Entities

  • Scorpius Holdings, Inc. (company) — Registrant
  • June 30, 2025 (date) — Date of earliest event reported
  • NightHawk Biosciences, Inc. (company) — Former company name
  • HEAT BIOLOGICS, INC. (company) — Former company name

FAQ

What is the nature of the material definitive agreement entered into by Scorpius Holdings, Inc. on June 30, 2025?

The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this summary section.

What type of direct financial obligation did Scorpius Holdings, Inc. incur?

The filing states that Scorpius Holdings, Inc. incurred a direct financial obligation, but the specific terms and amount are not detailed in this summary.

What was the date of the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on June 30, 2025.

Has Scorpius Holdings, Inc. previously operated under different names?

Yes, Scorpius Holdings, Inc. was formerly known as NightHawk Biosciences, Inc. and prior to that, HEAT BIOLOGICS, INC.

What are the main items reported in this 8-K filing?

This 8-K filing reports on the entry into a material definitive agreement, the creation of a direct financial obligation, unregistered sales of equity securities, and includes financial statements and exhibits.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding Scorpius Holdings, Inc. (SCPX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.